Differential cardiometabolic outcomes of leuprolide versus spironolactone in women with polycystic ovary syndrome
Leuprolide therapy was associated with improved lipid and hypertension outcomes compared to spironolactone. These findings support leuprolide's potential role in broader metabolic management of PCOS.
Authors
- Jeffrey P. Weiss (ORCID: https://orcid.org/0000-0001-9564-2724)
- Jason Lazar (ORCID: https://orcid.org/0000-0002-8548-7932)
- Robert A. Adler (ORCID: https://orcid.org/0000-0002-2019-0417)
- Esther Auerbach
- Michael Kozlov (ORCID: https://orcid.org/0009-0009-2412-4271)
- Myles Goliger
- Jacob Givoni
Institutions
- University of Central Florida (US)
- State University of New York (US)
- SUNY Downstate Health Sciences University (US)
- Kings County Hospital Center (US)
Publication Details
- Journal
- Baylor University Medical Center Proceedings
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1080/08998280.2025.2605612
- Citations
- 1
- Primary Topic
- Ovarian function and disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.70